Join leading regulatory experts from Japan, Singapore, and South Korea for a webinar exploring CGT approval pathways across three key APAC jurisdictions. Based on the recently published ISCT APAC Industry Committee regulatory roadmap in Cytotherapy, this session provides practical insights for navigating complex regional regulatory landscapes.Our distinguished panelists will share emerging trends and recent updates in APAC cell and gene therapy regulations, including regulated access to unapproved and unproven therapies and real-world case studies from their respective markets. Learn about Singapore's risk-based CTGTP classification system, Japan's innovative conditional approval pathways, and South Korea's advanced biological products regulations.This is a must-attend webinar for regulatory affairs professionals, clinical developers, and business leaders seeking to unlock APAC opportunities while ensuring alignment between Eastern and Western regulatory approaches. Tune in for actionable insights that propels successful approval strategies, information on submission requirements, and development timelines that can accelerate your CGT programs in these rapidly expanding markets.